Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Earns Media Sentiment Rating of 1.82

Media coverage about Fisher & Paykel Healthcare (OTCMKTS:FSPKF) has been trending somewhat positive this week, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Fisher & Paykel Healthcare earned a media sentiment score of 1.82 on their scale. InfoTrie also assigned news coverage about the company an news buzz score of 5 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock’s share price in the next several days.

Fisher & Paykel Healthcare stock remained flat at $$10.10 during trading on Monday. Fisher & Paykel Healthcare has a twelve month low of $8.30 and a twelve month high of $10.80.

Separately, Goldman Sachs Group raised Fisher & Paykel Healthcare from a “sell” rating to a “neutral” rating in a research report on Thursday, February 21st.

ILLEGAL ACTIVITY NOTICE: “Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Earns Media Sentiment Rating of 1.82” was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems worldwide. The company offers its products for use in respiratory, acute care, and surgery; and for the treatment of obstructive sleep apnea (OSA).

Read More: Hedge Funds – Risk or Reward?

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with's FREE daily email newsletter.